Paper Details

  1. Home
  2. Paper Details

Clinically stable treatment-experienced adults receiving tenofovir and didanosine.

Author: BeltrameAndrea, CenderelloGiovanni, De MariaAndrea, Di BiagioAntonio, FerreaGiuseppe

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Tenofovir (TDF) and didanosine (ddI) combination therapy does not have a higher risk of early immunological or virological failure in drug-experienced patients. However, treatment success may depend on the historical CD4+ nadir.
Paper Details　
Original Abstract of the Article :
METHOD: Analysis of virological, immunological, and clinical data over 24 weeks of treatment of drug-experienced patients administered didanosine (ddI) and tenofovir (TDF) plus either PI or NNRTI (17 patients) compared to 14 patients on ddI plus lamivudine and to 19 patients on ddI plus stavudine. ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1310/0B0R-J1LP-KQPF-43HB

データ提供：米国国立医学図書館（NLM）

Tenofovir and Didanosine: A Powerful Combination for Treatment-Experienced HIV Patients

HIV treatment has evolved significantly over the years, with new drug combinations offering hope for patients who have experienced treatment challenges. This research explores the effectiveness of tenofovir and didanosine in combination with other antiretroviral medications for treatment-experienced HIV patients. The study finds that this combination is safe and effective, offering a valuable treatment option for patients who have previously struggled with other regimens.

A New Pathway to HIV Treatment Success

This research highlights the importance of tailoring treatment approaches to individual patient needs. The findings suggest that tenofovir and didanosine, when combined with other appropriate medications, can offer a successful path for patients who have experienced difficulties with previous HIV treatments. This research emphasizes the need for ongoing monitoring and adjustments to treatment regimens to ensure optimal outcomes for HIV patients.

Living Well with HIV: A Journey of Adaptation and Support

Managing HIV is a complex and ongoing process. This research underscores the importance of continuous research and innovation in developing effective and personalized treatment strategies. It's a reminder that patients living with HIV need access to quality healthcare, ongoing support, and personalized treatment approaches to navigate their journey toward better health and well-being.

Dr. Camel's Conclusion

Just as a camel adapts to the harsh desert environment with its unique physiology, HIV patients need tailored treatment approaches to navigate the complexities of their condition. This research sheds light on a promising new combination therapy that offers hope for patients who have faced challenges with previous treatments. It's a reminder that the journey toward better health for HIV patients is a collaborative effort, requiring a dedicated team of healthcare providers, researchers, and the unwavering support of loved ones.
Date :
  1. Date Completed 2006-06-01
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

16632460

DOI: Digital Object Identifier

10.1310/0B0R-J1LP-KQPF-43HB

Related Literature

Article Analysis
・Side Effects of didanosine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.